Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$25M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 1 filing we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 6 most recent Form 4 transactions.
| Kailera Therapeutics, Inc. |
| PBUY |
| 1.6M |
| $16.00 |
| $25M |
| +7.4% |
| Open the original filing on SEC.gov |
| Apr 20 | KLRA | Kailera Therapeutics, Inc. | CCONV | 4.1M | — | — | +24.6% | Open the original filing on SEC.gov |
| Apr 20 | KLRA | Kailera Therapeutics, Inc. | CCONV | 16.9M | — | — | — | Open the original filing on SEC.gov |
| Apr 16 | KLRA | Kailera Therapeutics, Inc. | AGRANT◆ | 38,300 | — | — | — | Open the original filing on SEC.gov |